Health Catalyst Inc. Stock News

There are several underlying growth drivers further driving the adoption for HCAT solutions. HCAT differentiated product offering, strong M&A track record, and ability to further penetrate existing ba

Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.

Health Catalyst, Inc., after a 74% downside, spells opportunity, especially when ratings are all favorable. However, analysts at Evercore think differently and have downgraded Health Catalyst stock.

SALT LAKE CITY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,

The company continued its upward trend in revenue growth.

Health Catalyst, Inc. (NASDAQ:HCAT ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Adam Brown - Senior Vice President-Finance and Investor Relations Daniel Burton -

Health Catalyst (HCAT) delivered earnings and revenue surprises of 35% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SALT LAKE CITY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,

Health Catalyst has been on my "Bio Boom" watch list for a couple of years, but the valuation has stopped me from starting a position. The market-wide sell-off has brought the share price down to an a

SALT LAKE CITY, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,

Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Adam Brown – Senior Vice President-Finance and Investor Relations Dan Burton –

Health Catalyst (HCAT) delivered earnings and revenue surprises of 72.73% and 1.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

When equities are under pressure, it is particularly important for investors to find stocks that are trading at a discount to their intrinsic value. This can be particularly difficult if you're intere

SALT LAKE CITY, July 21, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,

SALT LAKE CITY, June 01, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,